annual cash & cash equivalents:
$606.10M+$39.80M(+7.03%)Summary
- As of today (May 29, 2025), DXCM annual cash & cash equivalents is $606.10 million, with the most recent change of +$39.80 million (+7.03%) on December 31, 2024.
- During the last 3 years, DXCM annual cash & cash equivalents has fallen by -$446.50 million (-42.42%).
- DXCM annual cash & cash equivalents is now -46.69% below its all-time high of $1.14 billion, reached on December 31, 2018.
Performance
DXCM Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$904.90M+$298.80M(+49.30%)Summary
- As of today (May 29, 2025), DXCM quarterly cash & cash equivalents is $904.90 million, with the most recent change of +$298.80 million (+49.30%) on March 31, 2025.
- Over the past year, DXCM quarterly cash & cash equivalents has increased by +$53.70 million (+6.31%).
- DXCM quarterly cash & cash equivalents is now -37.35% below its all-time high of $1.44 billion, reached on September 30, 2021.
Performance
DXCM quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DXCM Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.0% | +6.3% |
| 3 y3 years | -42.4% | +26.4% |
| 5 y5 years | +35.8% | +54.8% |
DXCM Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.4% | +7.0% | -24.3% | +59.8% |
| 5 y | 5-year | -42.4% | +35.8% | -37.4% | +70.7% |
| alltime | all time | -46.7% | >+9999.0% | -37.4% | >+9999.0% |
DXCM Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $904.90M(+49.3%) |
| Dec 2024 | $606.10M(+7.0%) | $606.10M(-2.4%) |
| Sep 2024 | - | $621.20M(-33.9%) |
| Jun 2024 | - | $939.20M(+10.3%) |
| Mar 2024 | - | $851.20M(+50.3%) |
| Dec 2023 | $566.30M(-11.8%) | $566.30M(-12.0%) |
| Sep 2023 | - | $643.70M(-46.1%) |
| Jun 2023 | - | $1.19B(+91.7%) |
| Mar 2023 | - | $623.20M(-3.0%) |
| Dec 2022 | $642.30M(-39.0%) | $642.30M(-8.0%) |
| Sep 2022 | - | $698.10M(-5.1%) |
| Jun 2022 | - | $735.40M(+2.7%) |
| Mar 2022 | - | $716.00M(-32.0%) |
| Dec 2021 | $1.05B(+28.7%) | $1.05B(-27.1%) |
| Sep 2021 | - | $1.44B(+24.6%) |
| Jun 2021 | - | $1.16B(+57.9%) |
| Mar 2021 | - | $733.80M(-10.2%) |
| Dec 2020 | $817.60M(+83.2%) | $817.60M(+21.4%) |
| Sep 2020 | - | $673.50M(+27.1%) |
| Jun 2020 | - | $530.00M(-9.3%) |
| Mar 2020 | - | $584.60M(+31.0%) |
| Dec 2019 | $446.20M(-60.8%) | $446.20M(+12.8%) |
| Sep 2019 | - | $395.60M(-44.2%) |
| Jun 2019 | - | $709.20M(-44.8%) |
| Mar 2019 | - | $1.29B(+13.0%) |
| Dec 2018 | $1.14B(+157.5%) | $1.14B(+209.5%) |
| Sep 2018 | - | $367.40M(+22.4%) |
| Jun 2018 | - | $300.20M(-28.6%) |
| Mar 2018 | - | $420.40M(-4.8%) |
| Dec 2017 | $441.50M(+367.2%) | $441.50M(+9.8%) |
| Sep 2017 | - | $402.10M(+1.6%) |
| Jun 2017 | - | $395.90M(+157.9%) |
| Mar 2017 | - | $153.50M(+62.4%) |
| Dec 2016 | $94.50M(+9.8%) | $94.50M(-3.3%) |
| Sep 2016 | - | $97.70M(+11.7%) |
| Jun 2016 | - | $87.50M(+12.3%) |
| Mar 2016 | - | $77.90M(-9.5%) |
| Dec 2015 | $86.10M(+19.9%) | $86.10M(+0.9%) |
| Sep 2015 | - | $85.30M(+26.0%) |
| Jun 2015 | - | $67.70M(+24.9%) |
| Mar 2015 | - | $54.20M(-24.5%) |
| Dec 2014 | $71.80M | $71.80M(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $63.20M(+27.7%) |
| Jun 2014 | - | $49.50M(+8.3%) |
| Mar 2014 | - | $45.70M(+5.8%) |
| Dec 2013 | $43.20M(+433.3%) | $43.20M(+29.3%) |
| Sep 2013 | - | $33.40M(+18.4%) |
| Jun 2013 | - | $28.20M(+49.2%) |
| Mar 2013 | - | $18.90M(+133.3%) |
| Dec 2012 | $8.10M(+211.5%) | $8.10M(+70.7%) |
| Sep 2012 | - | $4.74M(-20.7%) |
| Jun 2012 | - | $5.99M(+16.9%) |
| Mar 2012 | - | $5.12M(+96.9%) |
| Dec 2011 | $2.60M(-46.8%) | $2.60M(-85.2%) |
| Sep 2011 | - | $17.52M(-48.3%) |
| Jun 2011 | - | $33.89M(+790.6%) |
| Mar 2011 | - | $3.81M(-22.2%) |
| Dec 2010 | $4.89M(+36.7%) | $4.89M(-11.6%) |
| Sep 2010 | - | $5.53M(-9.2%) |
| Jun 2010 | - | $6.09M(-43.1%) |
| Mar 2010 | - | $10.70M(+199.1%) |
| Dec 2009 | $3.58M(-71.8%) | $3.58M(-43.8%) |
| Sep 2009 | - | $6.36M(+51.2%) |
| Jun 2009 | - | $4.21M(-54.6%) |
| Mar 2009 | - | $9.28M(-27.0%) |
| Dec 2008 | $12.70M(-45.1%) | $12.70M(+173.6%) |
| Sep 2008 | - | $4.64M(-6.5%) |
| Jun 2008 | - | $4.96M(-79.3%) |
| Mar 2008 | - | $23.95M(+3.6%) |
| Dec 2007 | $23.11M(+27.2%) | $23.11M(+52.3%) |
| Sep 2007 | - | $15.18M(-41.4%) |
| Jun 2007 | - | $25.88M(-53.6%) |
| Mar 2007 | - | $55.83M(+207.3%) |
| Dec 2006 | $18.17M(-51.2%) | $18.17M(-21.7%) |
| Sep 2006 | - | $23.20M(-3.2%) |
| Jun 2006 | - | $23.98M(+18.8%) |
| Mar 2006 | - | $20.18M(-45.8%) |
| Dec 2005 | $37.25M(+36.8%) | $37.25M(-11.6%) |
| Sep 2005 | - | $42.12M(-18.2%) |
| Jun 2005 | - | $51.49M(+1008.7%) |
| Mar 2005 | - | $4.64M |
| Dec 2004 | $27.23M(+36.0%) | - |
| Dec 2003 | $20.02M(+157.4%) | - |
| Dec 2001 | $7.78M(-44.0%) | - |
| Dec 2000 | $13.90M | - |
FAQ
- What is DexCom annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for DexCom?
- What is DexCom annual cash & cash equivalents year-on-year change?
- What is DexCom quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for DexCom?
- What is DexCom quarterly cash & cash equivalents year-on-year change?
What is DexCom annual cash & cash equivalents?
The current annual cash & cash equivalents of DXCM is $606.10M
What is the all time high annual cash & cash equivalents for DexCom?
DexCom all-time high annual cash & cash equivalents is $1.14B
What is DexCom annual cash & cash equivalents year-on-year change?
Over the past year, DXCM annual cash & cash equivalents has changed by +$39.80M (+7.03%)
What is DexCom quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DXCM is $904.90M
What is the all time high quarterly cash & cash equivalents for DexCom?
DexCom all-time high quarterly cash & cash equivalents is $1.44B
What is DexCom quarterly cash & cash equivalents year-on-year change?
Over the past year, DXCM quarterly cash & cash equivalents has changed by +$53.70M (+6.31%)